What is Forte Biosciences Forward Dividend Yield %?
As of today (2024-05-26), the Forward Annual Dividend Yield of Forte Biosciences is 0.00%.
As of today (2024-05-26), the Trailing Annual Dividend Yield of Forte Biosciences is 0.00%.
FBRX's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.6 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Forte Biosciences's Forward Dividend Yield %
For the Biotechnology subindustry, Forte Biosciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forte Biosciences's Forward Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Forte Biosciences's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Forte Biosciences's Forward Dividend Yield % falls into.
Forte Biosciences Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Forte Biosciences (NAS:FBRX) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Forte Biosciences Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Forte Biosciences's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Forte Biosciences (Forte Biosciences) Business Description
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA"). The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FBRX has been successfully added to your